Showing results (1-10 of 191) with videos related to
Sort By:
Pageof 20
The Journal of Antibiotics|March 1, 1992
3'-Hydroxyesorubicin halogenated at C-2'W Priebe, N Neamati, R Perez-solerThe Journal of Antibiotics|July 1, 1990
3'-Hydroxyesorubicin. Synthesis and antitumor activityW Priebe, N Neamati, R Perez-SolerCancer Research|July 15, 1990
Anthracycline antibiotics with high liposome entrapment: structural features and biological activityR Perez-Soler, W PriebeCancer Chemotherapy and Pharmacology|January 1, 1992
Liposomal formulation and antitumor activity of 14-O-palmitoyl-hydroxyrubicinR Perez-Soler, W PriebePharmacology & Therapeutics|November 1, 1993
Design and tumor targeting of anthracyclines able to overcome multidrug resistance: a double-advantage approachW Priebe, R Perez-SolerInternational Journal of Cancer|March 28, 1997
Annamycin circumvents resistance mediated by the multidrug resistance-associated protein (MRP) in breast MCF-7 and small-cell lung UMCC-1 cancer cell lines selected for resistance to etoposideR Perez-Soler, N Neamati, Y Zou, et al.Cancer Chemotherapy and Pharmacology|January 1, 1996
Lyophilized preliposomal formulation of the non-cross-resistant anthracycline annamycin: effect of surfactant on liposome formation, stability and sizeY Zou, W Priebe, R Perez-SolerCancer Research|April 15, 1993
Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cellsY H Ling, W Priebe, R Perez-SolerJournal of Pharmaceutical Sciences|November 1, 1993
Quantitative analysis of the lipophilic doxorubicin analogue annamycin in plasma and tissue samples by reversed-phase chromatographyY Zou, A Hayman, W Priebe, et al.Cancer Chemotherapy and Pharmacology|January 1, 1993
Organ distribution and tumor uptake of annamycin, a new anthracycline derivative with high affinity for lipid membranes, entrapped in multilamellar vesiclesY Zou, W Priebe, Y H Ling, et al.Pageof 20